You have 9 free searches left this month | for more free features.

everolimus

Showing 1 - 25 of 384

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • Everolimus
  • (no location specified)
Aug 15, 2022

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Breast Cancer Trial in New Haven (Everolimus)

Terminated
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Uterine Sarcoma Trial (Everolimus)

Available
  • Uterine Sarcoma
  • Everolimus
  • (no location specified)
Jun 30, 2021

Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

Active, not recruiting
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022

Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)

Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Oct 12, 2021

Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)

Completed
  • Epilepsy
  • +2 more
  • Everolimus
  • New York, New York
    New York University Langone Medical Center
Aug 31, 2021

Breast Cancer, Ovarian Cancer Trial in Sioux Falls (niraparib, everolimus)

Active, not recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Aug 24, 2021

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Kidney Transplant Infection Trial in São Paulo (Sirolimus, Everolimus, Mycophenolic acid)

Completed
  • Kidney Transplant Infection
  • São Paulo, Sao Paulo, Brazil
    Hospital do Rim
Aug 23, 2021

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

Terminated
  • Waldenstrom's Macroglobulinemia
  • Everolimus
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 22, 2021

Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)

Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)

Completed
  • Breast Cancer
  • Everolimus
  • +4 more
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • everolimus
  • +5 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 19, 2021

Prostate Cancer Trial in New York (apalutamide, Everolimus)

Completed
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 29, 2021

Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)

Active, not recruiting
  • Pancreatic Neuroendocrine Tumors
  • everolimus
  • Beijing, Beijing, China
  • +3 more
Sep 27, 2021